Impacts
We’re proud of our founders’ work to clearly define the impact that stems
from the achievement of their business goals. Those self-defined
impacts map to more than 50 IRIS+ impact metrics. Here is a snapshot:
Have metrics aligned with environmental outcomes
50%
A sample of 2025 metrics
Pounds of organic matter diverted from landfill
Number of trees preserved through alternative ingredient production
Have metrics aligned with
health outcomes
65%
A sample of 2025 metrics
Number of customers placing healthy orders weekly on company platform
Number of weekly shoppers using nutrition-based product ratings
Amount of sugar consumption reduced
Have metrics aligned with
diversity outcomes
50%
A sample of 2025 metrics
Percent of customers gaining access to financing
Established and maintained hiring practices to ensure equal opportunity
Percent of program participans from underrepresented backgrounds
A sample of 2025 metrics
Supply Change Capital portfolio companies define impact metrics that align with their business goals and they report on them annually.
Learn about our
five-step impact process
Our investment thesis is guided by our framework, which illustrates the expected change and its context, visualizing short-term activities leading to long-term impact.
Integrated into our diligence process, we screen a company’s’ current or projected impacts across three key dimensions of diversity, environment, and health, using a standard rubric.
Our impact expectations are formalized in an investment side letter. An annual questionnaire allows companies to track their impacts across IRIS+ aligned indicator metrics.
Alveo Technologies is a molecular diagnostics company delivering handheld, lab-quality pathogen detection at the point of need across animal, environmental, and human health.
Number of tests shipped to enable rapid, in-field pathogen monitoring
Avian influenza detected 3-5 days faster than traditional PCR workflows, enabling earlier containment and reducing the scale of required culling
Alveo’s platform reimagines pathogen detection by delivering molecular precision outside traditional laboratory settings. The portable analyzer and test cartridges provide lab-quality results in under an hour, with molecular-level accuracy (98.3% sensitivity and >99% specificity for its Avian Influenza test currently on the market internationally).
Beyond speed, Alveo’s ecosystem includes secure cloud connectivity through its Alveo Vista™ platform, enabling geotagged, time-stamped results for real-time outbreak monitoring and surveillance. By moving testing to farms and field sites, the platform enables earlier detection— often days faster than traditional PCR workflows—creating value through prevention rather than reaction.
This shift is particularly critical in poultry. Timely results and biosecurity response both minimize the risk of spread to nearby farms and the impact on production, trade, and animal welfare. As outbreaks intensify globally, field-based, rapid diagnostics become foundational infrastructure for food system resilience.
“For the first time, producers and veterinarians can obtain confirmed, laboratory‑grade molecular results in less than an hour, directly at the farm. This advancement fundamentally reshapes decision‑making in the field, accelerates response times, and ensures authorities have access to reliable data when it matters most.”
— Mohamed Hussein, CEO of Global Animal Health Egypt
Hyfé is developing refining technology that allows food processors to convert crop waste into specialty ingredients and chemicals, fundamentally changing how the industry extracts value from its raw materials.
Tons of organic waste processed
Organic waste diverted from landfill
Conversion of byproducts into functional ingredients (e.g., antioxidants, soluble fibers)
Hyfé’s solvent-free refining technology converts over 96% of biomass into sellable products in minutes. Today Hyfé works with processors producing over 2.5 million tons of waste annually and generates revenue out of its pilot facility in San Francisco, where its bioactives and soluble fibers have already demonstrated performance advantages over incumbent products.
Hyfé’s process delivers higher yields and greater purities than conventional extraction methods, especially with polyphenol-rich biomasses, translating directly into better economics and better-performing ingredients.
Designed for co-location, Hyfé reduces feedstock handling costs and leverages existing infrastructure at processor facilities, lowering the capital required to reach scale while improving the utilization of assets that would otherwise sit idle in off seasons.
Food waste is generated globally, and Hyfé’s technology is designed to meet it there—enabling domestic and distributed manufacturing of essential goods wherever food processors operate. In the same way petroleum refineries adjust their output to meet market demand, Hyfé can shift its product portfolio to capture the highestvalue opportunities. Today the platform produces four product lines: bioactives, soluble fibers, insoluble fibers, and fermentable sugars. As markets evolve, the same technology can shift to the production of platform chemicals, positioning Hyfé as an enabler of a much broader industrial shift away from petroleum-derived goods.
Loamy is an AI-powered system of record for food shippers and growers that connects field-to-fork traceability, inventory, and operational workflows into a unified platform—enabling faster decisions, stronger compliance, and reduced waste.
Reduction in rejected truckloads across customer supply chains
Real-time tracking of product quality, documentation and inventory across shipments
Earlier identification of quality or compliance issues before products reach buyers
Loamy replaces fragmented workflows with a mobile-first, food-native system of record that unifies traceability, inventory, compliance, and operations in a single platform. Rather than requiring costly, multi-year ERP implementations, customers can begin with core workflows and expand over time. What differentiates Loamy is its embedded intelligence layer. By structuring operational data in real-time—from order intake to in-field quality checks—the platform replaces manual handoffs and siloed reporting with shared visibility across teams. AI-powered analysis and satellite-enabled monitoring surface potential quality and pricing risks earlier, enabling producers to make proactive decisions that reduce errors, prevent rejections, and improve margins before product reaches the shelf. By connecting growers, shippers, and manufacturers in a shared data layer, Loamy reduces preventable rejections, accelerates recall management, and minimizes avoidable food loss, strengthening transparency and operational resilience across the food system.
“Before it was really difficult to track and manage inspections that my 35 foremen were creating each week. Now with Loamy, I can actually track trends and be alerted to issues across the entire business much more quickly.”
– Sergio Lomeli, Food Safety Manager at Better Produce
People Science is a clinical research company that helps better-for-you brands and suppliers generate credible, real-world evidence through fast, regulatory-grade studies, all built and run on its proprietary platform, Chloe.
Percentage of research projects focused on women’s health or fertility
Regulatory-grade evidence generated for historically under-researched health conditions
Increased participation of women in decentralized clinical trials
People Science is a clinical research company that enables health and wellness companies to generate regulatory-grade clinical evidence through fast, decentralized studies. Its proprietary platform, Chloe (Consumer Health Learning and Organizing Ecosystem), allows companies to run rigorous trials entirely in participants’ homes, combining mobile data collection, wearable integrations, lab-based biomarker testing, and participant-reported outcomes in a single system. This model addresses a major gap in the wellness industry. Most clinical research infrastructure was built for pharmaceuticals, requiring in-person visits, long timelines, and high costs—making it impractical for many food, supplement, and wellness brands to generate credible evidence.
As consumers increasingly turn to AI tools to guide purchasing decisions, the absence of reliable data becomes even more consequential. More than half (58%) of consumers now use AI for product recommendations, and these systems prioritize products backed by detailed, validated information.25 By reducing the cost and time required to run rigorous studies—from years and hundreds of thousands of dollars to months—People Science enables more companies to generate credible evidence, helping ensure that data determines which health products are discovered, trusted, and scaled.